Phase I evaluation of interleukin-2-transfected irradiated allogeneic melanoma for the treatment of metastatic melanoma

Human Gene Therapy

Volumn 8, Issue 14, 1997, Pages 1701-1714

  Das Gupta, T K ^a   Cohen, E P ^a   Richards, J M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOPHENOL MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOLOGY; CLINICAL PROTOCOL; CYTOKINE RELEASE; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOGENETICS; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PROVIRUS; RETROVIRUS; SURVIVAL TIME; TOXICITY TESTING; X IRRADIATION;

EID: 0031580715     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.14-1701     Document Type: Article

References (0)